Ivanova Jivka T, Doukova Polet B, Boyanov Mihail A, Popivanov Plamen R
Department of Clinical Laboratory and Clinical Immunology, Alexandrovska Hospital, Medical University of Sofia, Sofia, Bulgaria.
Hormones (Athens). 2007 Jan-Mar;6(1):36-43.
The aim of this study was to search for a possible association of low bone mineral density (bMD) with the PvuII and XbaI polymorphisms of the estrogen receptor (Er) gene in bulgarian women.
400 bulgarian women participated in this study. bMD was measured at the lumbar spine, femoral neck and at the distal forearm. two groups were identified: women with normal bMD at both central sites (n=180) and women with low bMD at either site (n=220), designated as normal (NbMD) and low bMD (LbMD) groups, respectively. the genotype frequencies of PP, Pp, pp and XX, Xx, xx were investigated by Pcr and enzymatic digestion of the products by PvuII and XbaI.
The genotype frequencies were 12% for the PP, 59% for the Pp and 29% for the pp genotypes in the NbMD, and 26%, 50% and 24% in the LbMD groups, respectively. the XX, Xx, xx genotype frequencies were 14%, 63% and 23% in the NbMD, and 33%, 50% and 17% in the LbMD groups, respectively. the various genotypes were significantly associated with bMD. the relative risk for low bMD was higher for the XbaI marker (rr=1.51) than for the PvuII marker (rr=1.35). the association between low bMD and the polymorphisms under study was described by an etiological factor of 0.28 for the XbaI marker and 0.20 for the PvuII marker.
The specific XbaI and PvuII polymorphisms of the Er gene are associated with low bMD at all bMD measurement sites in the bulgarian female population. they might therefore become useful genetic markers in osteoporosis risk assessment in this specific population.
本研究旨在探寻保加利亚女性中低骨矿物质密度(BMD)与雌激素受体(Er)基因的PvuII和XbaI多态性之间可能存在的关联。
400名保加利亚女性参与了本研究。在腰椎、股骨颈和前臂远端测量BMD。确定了两组:两个中心部位BMD均正常的女性(n = 180)和任一部位BMD低的女性(n = 220),分别指定为正常BMD(NbMD)组和低BMD(LbMD)组。通过聚合酶链反应(PCR)以及用PvuII和XbaI对产物进行酶切来研究PP、Pp、pp和XX、Xx、xx的基因型频率。
在NbMD组中,PP、Pp和pp基因型的频率分别为12%、59%和29%,而在LbMD组中分别为26%、50%和24%。XX、Xx、xx基因型频率在NbMD组中分别为14%、63%和23%,在LbMD组中分别为33%、50%和17%。各种基因型与BMD显著相关。XbaI标记物导致低BMD的相对风险(RR = 1.51)高于PvuII标记物(RR = 1.35)。低BMD与所研究多态性之间的关联,对于XbaI标记物而言病因学因素为0.28,对于PvuII标记物而言为0.20。
Er基因特定的XbaI和PvuII多态性与保加利亚女性人群所有BMD测量部位的低BMD相关。因此,它们可能成为该特定人群骨质疏松症风险评估中有用的遗传标记物。